Gilead to license generic lenacapavir for HIV prophylaxis in 120 lower income countries. Dyer O. BMJ 2024;387:q2200.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dyer O. Gilead to license generic lenacapavir for HIV prophylaxis in 120 lower income countries. BMJ 2024;387:q2200.
PMID: 39374957